(Q40134306)

English

Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines

scientific article published on 28 August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

based on heuristic

inferred from title

measles vaccine

1 reference

based on heuristic

inferred from title

object named as

Peter Aaby

7

0 references

Christine Stabell Benn

5

object named as

Christine S Benn

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Amabélia Rodrigues

4

object named as

Amabelia Rodrigues

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

2

object named as

May-Lill Garly

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Hilton C. Whittle

6

object named as

Hilton Whittle

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

author name string

Cesario Martins

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Carlitos Bale

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

language of work or name

0 references

publication date

28 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

5766-5771

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.044

7 January 2021

Measles eradication in the Americas: progress to date

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.044

7 January 2021

Measles control efforts in urban Africa complicated by high incidence of measles in the first year of life

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.044

7 January 2021

Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.044

7 January 2021

Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.044

7 January 2021

Measles vaccination before nine months.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.044

7 January 2021

Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.044

7 January 2021

The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.044

7 January 2021

Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.044

7 January 2021

Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.044

7 January 2021

Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.044

7 January 2021

Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.08.044

7 January 2021

Identifiers

10.1016/J.VACCINE.2013.08.044

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40134306&oldid=2016358425"